About Doctor
Dr. Lee Jung-hee is among the best hematologist in Seoul, South Korea.
- Dr. Lee Jung-hee Education
-
- Doctor of Medicine : University of Ulsan
- Master of Medicine : University of Ulsan
- Bachelor of Medicine : Chung Ang University
- Dr. Lee Jung-hee major professional experiences
-
- Associate Professor in Hematology, UUCM AMC
- Assistant Professor in Hematology, UUCM AMC
- Assistant Professor in Internal Medicine, Chung Ang University Hospital
- Fellowship in HematoOncology, UUCM AMC
- Residency in Internal Medicine, UUCM AMC
- Internship in Chung Ang University Hospital
Hospital
Asan Medical Centre, Seoul, South Korea
Specialization
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma,
- Leukemia,
- Blood disease
Procedures Performed
- Bone marrow stem cell transplant
- Cell therapies
- Chemotherapy
Research & Publications
| Prognostic impact of lymphocyte subpopulations in peripheral blood after hematopoietic stem cell transplantation for hematologic malignancies. |
| The detailed kinetics of cytomegalovirus-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data. |
| A Case of Primary Bone Marrow Diffuse Large B-cell Lymphoma Presenting With Fibrillar Projections and Hemophagocytic Lymphohistiocytosis. |
| A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalan-prednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma. |
| Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors. |
| Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy. |
| Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma. |
| Prognostic significance of recurrent additional chromosomal abnormalities in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. |
| Prospective Randomized Comparison of Idarubicin and High-Dose Daunorubicin in Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia. |
| Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission. |
